The molecular target of EGCG in regard to PD risk is unclear, but it seems likely to be the 67kDa laminin receptor, stimulation of which by EGCG suppresses TLR4 expression in macrophages and a range of other cell types [184,185,186,187,188,189]. The gene discussed is TLR4; the disease is Parkinson disease.